Kirsty is a medicine used to control blood glucose (sugar) levels in patients from one year of age who have diabetes. Kirsty is a ‘biosimilar medicine’. This means that Kirsty is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. The reference medicine for Kirsty is NovoRapid. Kirsty contains the active substance insulin aspart.
Therapeutic Indication
### Therapeutic indication Kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Therapeutic Area (MeSH)
ATC Code
A10AB05
ATC Item
insulin aspart
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| insulin aspart | N/A | 门冬胰岛素 |
EMA Name
Kirsty (previously Kixelle)
Medicine Name
Kirsty (previously Kixelle)
Aliases
N/A
